Tyson MD, Morris D, Palou J, Rodriguez O, et al. Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study. J Urol 2023;209:890-900.
PMID: 37026631